| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Nitric oxide synthase, inducible|Hepatocyte NOS|HEP-NOS|Inducible NO synthase|Inducible NOS, iNOS|NOS type II|Peptidyl-cysteine S-nitrosylase NOS2|NOS2|NOS2A |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
mouse NOS2/iNOS (Nitric Oxide Synthase 2, Inducible) is a molecular target commonly studied in signal transduction, neuroscience, and metabolism research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of NOS2/iNOS is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of NOS2/iNOS can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
NOS2/iNOS (Nitric Oxide Synthase 2, Inducible) may also be referenced as Nitric oxide synthase, inducible, Hepatocyte NOS, and HEP-NOS in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how NOS2/iNOS relates to neuronal signaling and synaptic function, neuroinflammation, neurodegeneration models, and brain–body communication in signal transduction, neuroscience, and metabolism research.
- Interpreting shifts in NOS2/iNOS levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
NOS2/iNOS has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with signal transduction, neuroscience, and metabolism studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
CXCL16/CXCR6/TGF‐β Feedback Loop Between M‐MDSCs and Treg Inhibits Anti‐Bacterial Immunity During Biofilm Infection
IF: 14.1 Journal: Advanced Science Author: Department of Joint Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, 510080, China. Cited Date: 2025-10-24
Identification of potential anti-pneumonia pharmacological components of Glycyrrhizae Radix et Rhizoma after the treatment with Gan An He Ji oral liquid
IF: 14.026 Journal: Journal of Pharmaceutical Analysis Cited Date: 2022-08-11
Bioengineered chondrocyte membrane-camouflaged anti-ferroptotic drug-loaded liposomes: A highly effective cartilage-targeted drug delivery system for osteoarthritis treatment
IF: 13.3 Journal: Chemical Engineering Journal Author: National & Local Joint Engineering Research Center of Orthopaedic Biomaterials, Peking University Shenzhen Hospital, Shenzhen, Guangdong, PR China Cited Date: 2024-09-20
Fe-Capsaicin Nanozymes Attenuate Sepsis-Induced Acute Lung Injury via NF-κB Signaling
IF: 8 Journal: International Journal of Nanomedicine Author: Emergency Department, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People’s Republic of China Cited Date: 2024-01-12
Paeonol inhibits ACSL4 to protect chondrocytes from ferroptosis and ameliorates osteoarthritis progression
IF: 5.9 Journal: Journal of Orthopaedic Translation Author: National & Local Joint Engineering Research Centre of Orthopaedic Biomaterials, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China Cited Date: 2024-12-06
Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling
IF: 5.753 Journal: Cell Proliferation Cited Date: 2020-09-01
Inhibition of RAC1 activator DOCK2 ameliorates cholestatic liver injury via regulating macrophage polarisation and hepatic stellate cell activation
IF: 5.7 Journal: Biology Direct Author: Department of Pediatrics, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China. Cited Date: 2025-04-25